IP Library Granted Patent US 10,385,100
Granted Patent B2
US 10,385,100 · App. 15/221,021 · Granted Aug 20, 2019

Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids

Inventors: Eriks Rozners (Binghamton, NY); Thomas Zengeya (Frederick, MD)
Assignee: The Research Foundation for the State University o
C07K14/003C07K7/08C07K9/00C12Q1/6839
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,385,100
App. No.
15/221,021
Granted
Aug 20, 2019
Kind
B2
Abstract

Peptide nucleic acids containing thymidine and 2-aminopyridine (M) nucleobases formed stable and sequence selective triple helices with double stranded RNA at physiologically relevant conditions. The M-modified PNA displayed unique RNA selectivity by having two orders of magnitude higher affinity for the double stranded RNAs than for the same DNA sequences. Preliminary results suggested that nucleobase-modified PNA could bind and recognize double helical precursors of microRNAs.

Claims (29)

1. A peptide nucleic acid, comprising:

a polypeptide comprising a series of N-(2-aminoethyl)-glycines,

each N-(2-aminoethyl)-glycine being ligated to a respective Base,

and

wherein at least one of the respective Bases is 2-aminopyridine:

such that at least one N-(2-aminoethyl)-glycine ligated to a Base is 2-aminopyridine-ligated to a N-(2-aminoethyl)-glycine:

further comprising at least one basic amino acid ligated to the polypeptide.

2. The peptide nucleic acid according to claim 1 , wherein the at least one basic amino acid comprises at least one terminal lysine ligated to the polypeptide.

3. The peptide nucleic acid according to claim 1 , wherein at least four bases are 2-aminopyridine.

4. The peptide nucleic acid according to claim 1 , wherein at least two sequential bases are 2-aminopyridine.

5. The peptide nucleic acid according to claim 1 , wherein the polypeptide comprises at least six sequential base-ligated N-(2-aminoethyl)-glycines.

6. The peptide nucleic acid according to claim 1 , in combination with a double stranded RNA, wherein the peptide nucleic acid forms a base sequence selective triple helix with the double stranded RNA substantially without strand invasion.

7. The peptide nucleic acid according to claim 1 , wherein the peptide nucleic acid is configured to form a triple helix with a double stranded RNA having a corresponding base sequence with the peptide nucleic acid, substantially without strand invasion, which is stable at pH 7.4.

8. The peptide nucleic acid according to claim 7 , wherein the peptide nucleic acid is configured to form the triple helix with the double stranded RNA, in a base sequence-selective manner at pH 7.4 at a temperature of 37° C. in an aqueous buffer comprising 2 mM MgCl 2 , 90-mM KCl, 10 mM NaCl, and 50 mM potassium phosphate.

9. A peptide nucleic acid (PNA), comprising:

a polypeptide comprising a series of at least six N-(2-aminoethyl)-glycines,

each N-(2-aminoethyl)-glycine being ligated to a respective Base,

wherein at least one respective Base comprises 2-aminopyridine,

further comprising at least one basic amino acid ligated to the polypeptide.

10. The peptide nucleic acid according to claim 9 , wherein the at least one basic amino acid ligated to the polypeptide comprises lysine.

11. The peptide nucleic acid according to claim 9 , wherein at least two bases are 2-aminopyridine Bases.

12. The peptide nucleic acid according to claim 9 , wherein the polypeptide comprises at least six sequential base-ligated N-(2-aminoethyl)-glycines.

13. The peptide nucleic acid according to claim 9 , in combination with a double stranded RNA, wherein the peptide nucleic acid forms a base sequence-selective triple helix with the double stranded RNA.

14. A peptide nucleic acid (PNA), comprising a polypeptide comprising a series of N-(2-aminoethyl)-glycines, each N-(2-aminoethyl)-glycine being ligated to a respective base, wherein at least one respective base comprises 2-aminopyridine, configured to form a triple helix in sequence-selective manner with a double stranded ribonucleic acid which is stable at 37° C. in a pH 7.4 aqueous buffer comprising 2 mM MgCl 2 , 90-mM KCl, 10 mM NaCl, and 50 mM potassium phosphate.

15. The peptide nucleic acid according to claim 14 , configured to form, in combination with a double stranded RNA, a base sequence selective triple helix with the double stranded RNA substantially without strand invasion.

16. The peptide nucleic acid according to claim 14 , wherein at least one N-(2-aminoethyl)-glycine ligated to the respective base comprises:

17. The peptide nucleic acid according to claim 14 , further comprising at least one amino acid ligated to the series of N-(2-aminoethyl)-glycines.

18. The peptide nucleic acid according to claim 17 , wherein the at least one amino acid comprises lysine.

19. The peptide nucleic acid according to claim 9 , wherein at least one N-(2-aminoethyl)-glycine ligated to the respective Base comprises:

Continuity (3)
Division 14066006 · Oct 29, 2013
Provisional Application 61719691 · Oct 29, 2012
Related Publication 20170009280A1 · Jan 12, 2017